What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His main research concerns Surgery, Internal medicine, Randomized controlled trial, Tuberculosis and Acquired immunodeficiency syndrome.
His work carried out in the field of Surgery brings together such families of science as Pyrazinamide, Anesthesia, Clinical trial and Asthma.
His work in Internal medicine addresses subjects such as Allergy, which are connected to disciplines such as Methacholine, Cross-sectional study and Spirometer.
Andrew J. Nunn interconnects Placebo, Fibrinolytic agent and Physical therapy in the investigation of issues within Randomized controlled trial.
His studies deal with areas such as Lesion and Disease as well as Tuberculosis.
His research in Acquired immunodeficiency syndrome intersects with topics in Seroprevalence and Epidemiology.
His most cited work include:
- Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial (622 citations)
- U.K. Controlled trial of intrapleural streptokinase for pleural infection. (539 citations)
- Intrapleural use of tissue plasminogen activator and DNase in pleural infection (390 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Tuberculosis, Randomized controlled trial, Surgery and Clinical trial.
His Internal medicine study which covers Isoniazid that intersects with Streptomycin.
His Tuberculosis study combines topics in areas such as Regimen, Intensive care medicine, Pharmacotherapy, Pharmacology and Pediatrics.
In his study, Vaginal microbicide and Microbicides for sexually transmitted diseases is strongly linked to Placebo, which falls under the umbrella field of Randomized controlled trial.
He has researched Surgery in several fields, including Respiratory disease and Sputum.
The study incorporates disciplines such as Alternative medicine, Research design and Microbicide in addition to Clinical trial.
He most often published in these fields:
- Internal medicine (30.30%)
- Tuberculosis (28.96%)
- Randomized controlled trial (22.56%)
What were the highlights of his more recent work (between 2015-2021)?
- Tuberculosis (28.96%)
- Internal medicine (30.30%)
- Randomized controlled trial (22.56%)
In recent papers he was focusing on the following fields of study:
Andrew J. Nunn focuses on Tuberculosis, Internal medicine, Randomized controlled trial, Clinical trial and Regimen.
The concepts of his Tuberculosis study are interwoven with issues in Multiple drug resistance, Pharmacotherapy, Drug and Intensive care medicine.
His Internal medicine research integrates issues from Moxifloxacin, Pyrazinamide, Ethambutol and Standard treatment.
His Randomized controlled trial research entails a greater understanding of Surgery.
His Clinical trial research includes elements of Culture conversion, Health care, Cohort study, Economic evaluation and Alternative medicine.
His research integrates issues of Sensitivity analyses, Activity-based costing and Censoring, Informative censoring in his study of Regimen.
Between 2015 and 2021, his most popular works were:
- A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis (113 citations)
- Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial (87 citations)
- Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis (42 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Andrew J. Nunn mainly investigates Randomized controlled trial, Tuberculosis, Internal medicine, Clinical trial and Regimen.
His Randomized controlled trial research is within the category of Surgery.
The Tuberculosis study combines topics in areas such as Multiple drug resistance, Virology, Pharmacotherapy, Disease and Public health.
His Internal medicine study frequently links to adjacent areas such as Bullous pemphigoid.
His research investigates the connection with Clinical trial and areas like Cohort study which intersect with concerns in Odds ratio, Pyrazinamide, Intention-to-treat analysis, Equivalence Trial and Rifampicin.
His studies in Regimen integrate themes in fields like Culture conversion, Sputum, Gerontology, Moxifloxacin and Surrogate endpoint.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
